“This impressive achievement underscores Hesperos’ innovative Human-on-a-Chip organ system technology that provides drug and (other medical product) developers more informative results about their products, more quickly and at lower cost than conventional animal testing. This validation … Read More
Highlights Human IPSC-Derived PreBötC-Like Neurons and Development of an Opiate Overdose and Recovery Model, published in 2023 by Hesperos in Advanced Biology, has been recognized as a top viewed article in the journal.The study describes the … Read More
The U.S. Food and Drug Administration announced a Roadmap to Reducing Animal Testing in Preclinical Safety Studies by leveraging more effective, human relevant methods including technologies like our Human-on-a-Chip! This exciting announcement outlines a 3-year strategic … Read More
Our team had the privilege of the Society of Toxicology (SOT) Annual Meeting and ToxExpo 2025 March 16-20th. SOT brought experts in the field of toxicology together for five days of scientific sessions, poster presentations, and … Read More
In loving memory of Jeffrey M. Anderson February 16, 1957 – March 1, 2025 We are deeply saddened to announce the passing of Jeffrey M. Anderson, PhD. Dr. Anderson passed away on March 1, 2025, after … Read More
“[This] is a demonstration of how these novel technologies can be leveraged to develop a new treatment paradigm – moving away from the one-treatment-fits-all perspective and towards the development of personalized medicines,” Mihael H. Polymeropoulos, M.D., … Read More
Ask Me Anything: Body-On-A-Chip Michael Shuler, PhD was featured on Technology Network’s Ask Me Anything: Body-On-A-Chip webinar and answered questions from a live audience. January 31, 2025: Hosted by Technology Networks, Hesperos President Michael Shuler, PhD, … Read More
ORLANDO, FLORIDA – Researchers from Hesperos and the University of Central Florida have developed a groundbreaking model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to better understand and combat Alzheimer’s disease (AD). Their research, published in Alzheimer’s and Dementia, aims to improve our understanding and treatment of the disease.
FOR IMMEDIATE RELEASE ORLANDO, FL – October 24, 2024 – Hesperos, a leader in human-on-a-chip technology, has announced a breakthrough with the development of a human induced pluripotent stem cell (iPSC)-derived model of peripheral myelination. Published … Read More
Hesperos Appoints L. Florin as CEO “I am excited to join Hesperos during this period of explosive growth […and] lead this exceptional team as we continue delivering breakthrough solutions that advance drug discovery and benefit patients … Read More